Envista (NYSE:NVST) Sets New 52-Week High on Better-Than-Expected Earnings

Envista Holdings Corporation (NYSE:NVST)’s share price hit a new 52-week high on Friday following a better than expected earnings announcement. The company traded as high as $28.80 and last traded at $28.5230, with a volume of 994454 shares trading hands. The stock had previously closed at $24.71.

The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.55%. The firm had revenue of $750.60 million during the quarter, compared to analyst estimates of $680.26 million. During the same quarter in the prior year, the business posted $0.24 EPS. The business’s revenue was up 15.0% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS.

More Envista News

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Q4 results beat expectations — Envista reported $0.38 EPS vs. $0.32 consensus and revenue of $750.6M versus ~ $680M est., with revenue up ~15% year-over-year. Strong results are the primary driver of the move higher. Envista Reports Fourth Quarter 2025 Results
• Positive Sentiment: Management raised FY‑2026 EPS guidance to $1.35–$1.45 vs. consensus ~ $1.27 — the stronger outlook (and beat + guidance combo) is supportive of the rally and suggests better-than-expected near-term growth. Press Release / Slide Deck
• Neutral Sentiment: Earnings materials and call transcripts are available for deeper read — the conference call transcript and slide deck provide management commentary on drivers (product mix, geographic trends, margins) that investors should review to judge sustainability. Earnings Call Transcript Earnings Presentation
• Neutral Sentiment: Wall‑street writeups and snapshots (Zacks, Yahoo, Investing) highlight the beat and value/Growth characteristics — useful for screening but not new catalysts by themselves. Zacks Q4 Metrics
• Negative Sentiment: Analyst targets still imply downside — JPMorgan and Wells Fargo both raised targets to $26 but kept neutral/equal‑weight ratings; those $26 targets sit below the current market level, which could cap upside or prompt caution once headline momentum fades. Benzinga – JPMorgan Benzinga – Wells Fargo

Analysts Set New Price Targets

A number of brokerages recently commented on NVST. Wells Fargo & Company lifted their price target on Envista from $21.00 to $26.00 and gave the stock an “equal weight” rating in a report on Friday. Barclays assumed coverage on Envista in a research report on Monday, December 8th. They set an “overweight” rating and a $24.00 target price for the company. Evercore reissued an “outperform” rating and issued a $32.00 price target on shares of Envista in a report on Friday. Evercore ISI set a $32.00 price objective on shares of Envista and gave the stock an “outperform” rating in a report on Friday. Finally, Stifel Nicolaus set a $31.00 price objective on shares of Envista in a research report on Friday. Eight research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $26.50.

Hedge Funds Weigh In On Envista

Hedge funds have recently made changes to their positions in the stock. Farther Finance Advisors LLC boosted its stake in Envista by 317.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after purchasing an additional 1,026 shares during the period. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after buying an additional 1,504 shares in the last quarter. Allworth Financial LP lifted its holdings in shares of Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after buying an additional 776 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after acquiring an additional 949 shares during the period. Finally, IFP Advisors Inc grew its stake in Envista by 102.9% during the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after acquiring an additional 1,071 shares in the last quarter.

Envista Stock Up 18.0%

The company has a current ratio of 2.37, a quick ratio of 2.02 and a debt-to-equity ratio of 0.47. The firm has a market cap of $4.80 billion, a P/E ratio of 104.18, a price-to-earnings-growth ratio of 1.10 and a beta of 1.01. The stock’s fifty day moving average is $22.80 and its two-hundred day moving average is $21.23.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.